Secretary of Commerce Howard Lutnick is the first Secretary of Commerce to ever be a patented inventor and is a named ...

Dormitzer also took the lead on Pfizer's respiratory syncytial virus (RSV) vaccine candidates ... such as mRNA, structure-based antigen design and synthetic biology, will be key to ensuring ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related ...

The patient's sample is added to the port, where antibodies targeting the virus fusion protein can bind the antigen in the sample. Capillary action migrates the resultant complex along the strip ...

It is manufactured using ADMA’s unique, patented plasma donor screening methodology and tailored plasma pooling design, which blends normal source plasma with respiratory syncytial virus plasma ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued ...

GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrative – and likely ...

The global point of care diagnostics market size is expected to reach USD 68.5 billion by 2030, registering a CAGR of 5.8% from 2025 to 2030, according ...

Apr. 17, 2025 — A vaccine under development has demonstrated complete protection in mice against a deadly variant of the virus that causes bird flu. The work focuses on the H5N1 variant known as ...

A briefing document from the Food and Drug Administration (FDA) says that enrollment for all clinical studies of vaccines for respiratory syncytial virus (RSV) in infants is on hold over concerns ...